Composition and method for treating hemorrhoids and/or anorectal disorders

1. A pharmaceutical composition consisting of 1.00% w/w pramoxine hydrochloride, 0.250% w/w phenylephrine hydrochloride, 15.0% w/w white petrolatum, 14.4% w/w glycerin, 1.00% w/w steareth-20, 1.00% w/w steareth-2, 3.00% w/w glyceryl monostearate and laureth-23 70/30, 5.00% w/w stearyl alcohol, 5.00% w/w cetyl alcohol, 0.200% w/w methylparaben, 0.100% w/w propylparaben, 0.200% w/w sodium benzoate, 0.0500% w/w disodium edetate, 0.500% w/w mixed tocopherols, 0.200% w/w propyl gallate and BHA in propylene glycol, 0.250% w/w sodium carboxymethylcellulose, 0.100% w/w xanthan, 0.200% w/w citric acid, 0.100% w/w aloe vera oil, 0.100% w/w vitamin E acetate, 1.00% w/w D-panthenol, and 51.35% w/w water; wherein the pharmaceutical composition is an oil-in-water emulsion and the oil-in-water emulsion is a cream, wherein the pramoxine hydrochloride and phenylephrine hydrochloride are solubilized in the water portion of the oil-in-water emulsion, wherein the at least one non-ionic emulsifier includes an ethoxylated fatty alcohol that is a solid at room temperature, wherein the ratio of the glycerin amount by weight to the sum of the glycerin amount and water by weight is about 20% to about 45%, wherein the pH range of the composition is about 3.5 to about 4.2, and wherein the composition provides hydration to hemorrhoid and/or anorectal tissue.

2. A method of treating hemorrhoids and/or anorectal disorders in humans comprising administering to the anorectal region a safe and effective amount of a pharmaceutical composition, the pharmaceutical composition consisting of 1.00% w/w pramoxine hydrochloride, 0.250% w/w phenylephrine hydrochloride, 15.0% w/w white petrolatum, 14.4% w/w glycerin, 1.00% w/w steareth-20, 1.00% w/w steareth-2, 3.00% w/w glyceryl monostearate and laureth-23 70/30, 5.00% w/w stearyl alcohol, 5.00% w/w cetyl alcohol, 0.200% w/w methylparaben, 0.100% w/w propylparaben, 0.200% w/w sodium benzoate, 0.0500% w/w disodium edetate, 0.500% w/w mixed tocopherols, 0.200% w/w propyl gallate and BHA in propylene glycol, 0.250% w/w sodium carboxymethylcellulose, 0.100% w/w xanthan, 0.200% w/w citric acid, 0.100% w/w aloe vera oil, 0.100% w/w vitamin E acetate, 1.00% w/w D-panthenol, and 51.35% w/w water;

wherein the pharmaceutical composition is an oil-in-water emulsion and the oil-in-water emulsion is a cream, wherein the pramoxine hydrochloride and phenylephrine hydrochloride are solubilized in the water portion of the oil-in-water emulsion, wherein the at least one non-ionic emulsifier includes an ethoxylated fatty alcohol that is a solid at room temperature, wherein the ratio of the glycerin amount by weight to the sum of the glycerin amount and water by weight is about 20% to about 45%, wherein the pH range of the composition is about 3.5 to about 4.2, and wherein the composition provides hydration to hemorrhoid and/or anorectal tissue.